Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-18T07:59:38.324Z Has data issue: false hasContentIssue false

The family burden of paediatric heart disease during the chronic phase of illness

Published online by Cambridge University Press:  28 November 2023

Kevin Hummel*
Affiliation:
Department of Pediatrics, University of Utah, Salt Lake City, UT, USA Intermountain Health Primary Children’s Hospital, Salt Lake City, UT, USA
Avital Ludomirsky
Affiliation:
Department of Cardiology, Childrens Hospital of Philadelphia, Philadelphia, PA, USA
Lauren Burgunder
Affiliation:
Department of Pediatrics, University of Utah, Salt Lake City, UT, USA Intermountain Health Primary Children’s Hospital, Salt Lake City, UT, USA
Minmin Lu
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Boston, MA, USA
Sarah Goldberg
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Boston, MA, USA
Lynn Sleeper
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Boston, MA, USA
Jeffrey Reichman
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Boston, MA, USA
Elizabeth D. Blume
Affiliation:
Department of Cardiology, Boston Children’s Hospital, Boston, MA, USA
*
Corresponding author: K. Hummel; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background:

CHD is a lifelong condition with a significant burden of disease to patients and families. With increased survival, attention has shifted to longer-term outcomes, with a focus on social determinants of health. Among children with CHD, socioeconomic status is associated with disparities in outcomes. Household material hardship is a concrete measure of poverty and may serve as an intervenable measure of socioeconomic status.

Methods:

A longitudinal survey study was conducted at multiple time points (at acute hospitalisation, then 12–24 months later in the chronic phase) to determine the prevalence of household material hardship among parents of children with advanced heart disease and quality of life during long-term follow-up.

Results:

The analytic cohort was 160 children with a median patient age of 1 year (IQR 1,4) with 54% of patients <2 years. During acute hospitalisation, over one-third of families reported household material hardship (37%), with significantly lower household material hardship in the chronic phase at 16% (N = 9 of 52). For parents reporting household material hardship during acute hospitalisation, 50% had resolution of household material hardship by the chronic phase. Household material hardship-exposed children were significantly more likely to be publicly insured (56% versus 20%, p = 0.03) with lower quality of life than those without household material hardship (64% versus 82%, p = 0.013).

Conclusion:

The burden of heart disease during the chronic phase of illness is high. Household material hardship may serve as a target to ensure equity in the care and outcomes of CHD patients and their families.

Type
Original Article
Copyright
© The Author(s), 2023. Published by Cambridge University Press

CHD is a lifelong, high-resource utilisation condition with peaks of substantial acuity in the setting of a chronic disease. While only representing a small percentage of overall patients in children’s hospitals, CHD is responsible for a significant burden of care, as is common with acute on chronic conditions. Reference Burstein, Shamszad and Dai1Reference Tuomela, Gordon, Cassidy, Johaningsmeir and Ghanayem4 This burden is experienced by the hospital and health system, in the form of long length of stays, unplanned readmissions, and significant time burden on a large number of sub-specialised providers. Reference Edelson, Rossano and Griffis2,Reference Islam, Kaul, Tran and Mackie3,5Reference Pasquali, Sun and d'Almada7 In addition, however, are the burden CHD places on families in relation to the value of care their child receives. Reference Lee, Miller, Daniels, Paine, Gresh and Betz8,Reference Porter9

Over the past decade, mortality from CHD continues to decline, and research has expanded to encompass specific burdens to patients and families. In particular, significant work has been undertaken to assess the effectiveness of transition to adult CHD management, neuropsychiatric and learning abilities, parental stress in the immediate post-operative period, and children’s emotional burdens. Reference Gerardin, Menk, Pyles, Martin and Lohr10Reference Vaikunth, Williams, Uzunyan, Tun, Barton and Chang12 However, most efforts target one point in time during acute illness, rather than the effect of CHD during the stable chronic phase of illness where patients and families spend most of their time. With the exception of assessing neurodevelopmental outcomes in children with CHD, which is now at the forefront of the field, there is a current lack of understanding and research into the stable chronic phase of CHD in terms of overall burden to families. Reference Sood, Karpyn and Demianczyk13Reference Marino, Lipkin and Newburger15

At a time of significant dynamic change in healthcare delivery, there is a need for greater understanding of not only the more longitudinal implications of CHD in terms of symptoms and medical needs but also the burden that families experience over time. It is demonstrated that as mortality declines across paediatric critical disease, morbidity increases yielding more longitudinal medical needs and a higher care burden for families. While McClung, et al. independently assessed financial burden from the National Survey of Children with Special Health Needs database two decades ago, there has not been an assessment of burden of care from individual families within a large Heart Center. Reference McClung, Glidewell and Farr16 Piloting this study to assess the burden of disease to families of children with CHD during the chronic stable phase will offer the opportunity to learn how to better serve patients with CHD with acute and chronic disease and their families.

Materials and methods

A prospective longitudinal study was conducted with a cohort of families of children with advanced heart disease. Families were queried for patient-reported outcomes and clinical data at time of acute illness and 12–24 months later to assess (1) overall burden of disease on families and (2) household medical hardship (a concrete measure of poverty including food or housing insecurity) at times of acute illness compared to the time of chronic disease. The study was conducted within a large, quaternary children’s hospital heart centre.

The initial cohort of patients and families was assessed in the acute hospital phase of illness as a part of a series of prior projects, which assessed parental and provider prognostic awareness, and household medical hardship. Reference Morell, Miller and Lu17 Acute hospital phase of illness was defined as hospitalised patients with advanced heart disease, which included patients < 19 years old with CHD or acquired heart disease and either length of stay > 30 days, mechanical ventilation > 14 days, > 2 admissions for heart disease-related issues in the past year, or actively listed for heart transplant. Stable chronic phase of illness included the same cohort of patients, but during the 12–24 months following initial inclusion in the cohort. It excluded patients who were readmitted at time of follow-up or those who had died following the initial, acute phase of illness. Patients were identified during clinic visits (either in-person or virtual) in the 12–24 month follow-up after initial survey, as all patients with the above criteria for advanced heart disease were followed longitudinally at a minimum of once annually within the quaternary centre, even if followed in parallel at local or regional centres.

Burden of disease was determined via a series of validated questions assessing time loss of school/work, financial losses, overall assessment of self-health, and patient symptom burden (utilising the EQ-5D single question assessment). Reference Willems Dëlle, Joore, Nieman, Severens, Wouters and Hendriks18 Predictors of overall burden of disease to families of children with advanced heart disease during stable chronic phase of illness included total number of days hospitalised over the past year, number of readmissions over the past year, number of days since the last surgery, and major complications (as defined by the Society of Thoracic Surgery) during the hospitalisation while enrolled in the study during the acute hospital phase of illness. Reference Franklin, Jacobs and Krogmann19

To assess household medical hardship, a previously validated tool was utilised, with questions surrounding food insecurity and housing insecurity, through the Hunger and Housing Stability Vital Sign Tools from Children’s Health Watch. Reference Baer, Scherer, Fleegler and Hassan20 These tools have previously demonstrated high validity and reliability in psychometric analysis. Reference Baer, Scherer, Fleegler and Hassan20Reference Berghammer, Karlsson, Ekman, Eriksson and Dellborg22 Additionally, a question assessing overcrowding was used (specific questions listed in Fig. 1). Children were classified as household medical hardship-exposed if their family endorsed any single question from the Hunger or Housing Stability Vital Sign Tools or overcrowded housing. Reference Baer, Scherer, Fleegler and Hassan20 The same questions were asked on the follow-up survey

Figure 1. Productivity burden percentages of total respondents by type of burden.

Data management and chart review

All survey responses were recorded in REDCap (Research Electronic Data Capture database;). Reference Harris, Taylor, Theilke, Payne, Gonzalez and Conde23 Acute data were collected from 2018 to 2019 and chronic data from 2020 to 2021. Research investigators verified the data to ensure accuracy and completeness. Each participant was assigned a unique study number. Some demographic, disease, and healthcare utilisation data were abstracted from the medical record by a trained research assistant and recorded in REDCap. Auto-queries and auto-validations were incorporated into REDCap during the design phase to minimise data entry error.

Statistical analysis

Descriptive statistics include mean ± standard deviation and median with interquartile range for continuous variables. Categorical data were described as number with frequency. Differences in characteristics between children with vs. without household medical hardship were evaluated with Fisher’s exact test, Student’s t-test, or Wilcoxon rank sum test as appropriate. A p-value of less than 0.05 was considered statistically significant. Analyses were performed using SAS 9.4. 24

Results

In the acute phase of illness, 160 parents or guardians were enrolled. Of the 160 surveys completed, 94% provided data for an analytic cohort of 150 children. Of patients enrolled, 101 (67%) were on the general cardiology wards and 105 (70%) had received the diagnosis of advance heart disease antenatally. Of the acute cohort, 76 (52.5%) of patients were female and in the majority of the families (71.9%) the respondent identified as white (Table 1).

Table 1. Patient demographics.

The median age of patients at acute parent enrolment was 1 year (median 1, IQR 1, 5) with the majority of patients (54%) < 2 years of age. Almost all patients (n = 149, 93.3%) had CHD. Half of families (53%) knew about the diagnosis for over one year. Among respondents completing the survey, the median age was 34 years old (range 17 to 56); 130 (87%) were mothers and 114 (76%) were married or living with a partner; the majority were privately insured (N = 109, 68%). Additionally, 97 (64%) had a college education or higher. Patients eligible for follow-up in the chronic cohort included 58 respondents of 160 initially enrolled patients (58/98, capture rate of 59%), with 34 excluded for either not reaching a phase of chronicity (being readmitted to the hospital during the preceding 12 months), loss-to-follow-up, and 28 inter-study mortalities. Compared with the acute cohort, the chronic cohort patient age was older (median 2 years versus 1 year), there were relatively more males (56% vs. 48%), and there was consistency in the predominance of white race (81%), though with lower rates of Black and other race/ethnicity than the acute cohort. 25 The majority of patients in the chronic cohort were privately insured (N = 39, 74%).

Indicators of family burden during the chronic stage of illness included functional status and perceived health status, productivity (time and finances) burdens, and household medical hardship:

Functional status

When asked about limitations in functional status, including symptoms and activity burden, functional status was a limitation in 60% of patients having some limitation (35/58), with 26% having at least marked limitation (15/58). On the EQ-5D scale of 1–100, with 100 being the highest answer, the average score for perceived health status of the child by the parent was 78%, below the median from other chronic conditions. Reference Balestroni and Bertolotti21,Reference Noyes and Edwards26

Productivity burden (Fig 1)

Over 1/3 (26/56, 39%) of families spend at least one hour per day caring for their child with CHD, with 10% (6/56) spending greater than four hours per day. All patients required daily medication, with 71% (41/58) taking multiple medications daily and 19% (11/58) requiring at least three times daily medications. Child school absenteeism included 60% missing some school on a monthly basis (21/35), with 26% (9/35) either missing at least 4 of 20 days per month or withdrawing from in-person school primarily due to cardiac condition. Siblings of children with CHD missed at least one day of school per month in 24% of families (9/37). The majority of parents of children with CHD missed at least a day of work in a given month (59%, 33/56). Financially, 42% (24/57) of families spend >$250 out-of-pocket (defined as any costs families paid for care from their perspective) in some form to care of their child per month and 9% (N = 1) spend >$1000 per month.

Household medical hardship

At the time of baseline survey, which was administration to acutely hospitalised families, 59/150 families were household medical hardship-exposed (39%) over the preceding 6 months. Of these, 41 (26%) endorsed food insecurity, 49 (31%) endorsed housing insecurity, with 31 (19%) endorsing both food and housing insecurity in the 6 months prior to the acute illness. In the follow-up assessment, following a period of>12 months out of the hospital, household medical hardship was significantly lower, with 16% of families reporting household medical hardship (9 of 58 reporting families). Most notably, for the parents who reported household medical hardship in the acute hospital phase who completed the follow-up survey (N = 20), 50% of these families had resolution of household medical hardship at the time assessed in chronic illness phase. There were no findings of patients that initially did not express household medical hardship exposure, then developed household medical hardship exposure in the chronic phase of illness.

Households with household medical hardship were more likely to be headed by a single-parent (45% vs. 12%, p < 0.001), who was non-college-educated (50% vs. 75%, p = 0.016) and of self-reported Hispanic ethnicity (27% versus 10%, p = 0.001). These households also had lower household income (median $25,000, IQR (12.5, 50.0) versus $120,000, IQR (70.0, 160.0), p < 0.001) (Table 2).

Table 2. Patient and parent demographics by household material hardship categorisation in the chronic phase of illness.

In univariate analyses, during the chronic phase of illness, compared to those without household medical hardship, those exposed to household medical hardship were more likely to be publicly insured than privately insured (56% vs. 20%, p = 0.03). QOL of respondents (EQ15) was queried only during the chronic phase of illness. Families who experienced household medical hardship while in the hospital during the acute phase of illness had a lower reported QOL by the parent on the EQ15 during the chronic phase, as compared to those in the acute phase who did not experience household medical hardship (64 ± 32% EQ15 score for respondents with household medical hardship during the acute phase of illness, versus 82 ± 17% for those who did not experience acute household medical hardship; p = 0.013; represents 36% of the acute cohort who completed the follow-up survey) (Fig. 2).

Figure 2. Quality of life during the chronic phase of illness. HMH = household medical hardship; IQR = interquartile range; QOL = quality of life.

Within three potential categories for free-text comments (related to symptom burden and financial burdens), 50% (29/58) provided responses during the chronic phase of illness. Of the symptom responses, 71% (12/17) were related to symptoms adding burden to daily life, while 29% (5/17) commented on a lack of symptoms or ability to achieve activity goals. Of these comments, 35% (6/17) related to burdens or stressors that the symptoms have placed on the family as opposed to the child alone. Of the financial comments, 44% (7/16) addressed either job loss or limited opportunity to work and 56% (9/16) related to costs of travel for care or housing during inpatient hospitalisations.

Discussion

Across families with children with advanced heart disease, during times of stability while not in the hospital, there is significant residual symptom burden, productivity burden in terms of work and school absenteeism, and costs. This pilot is the first report on burdens of paediatric heart disease in the chronic phase of illness. While this cohort represents a higher severity of illness than the congenital heart disease population as a whole, the study fills a void in the understanding of burdens families and patients are experiencing at a given point in time while in the chronic phase of illness. Patients with complex CHD quality of life which makes up the majority of the cohort—will require recurrent hospitalisations and procedures in the first several years of life. Reference Raissadati, Haukka, Pätilä, Nieminen and Jokinen27 Less attention is given to their and their families’ ability to live productive, low-symptom lives during the majority of their time, which is not spent in the hospital. In addition to what was learned during the acute illness, this study offered multiple opportunities for families to provide free-text comments to serve as feedback and ideas of the struggles families and patients face that care teams may not consider.

Functional status

The functional limitation and symptom impact on quality of life has had increased attention in the CHD population over the last several years. Neurodevelopmental programmes have begun implementing quality of life assessments and with the exponential growth of adults with CHD, programmes assessing adults with CHD wellness and transition programmes have developed. Reference Vaikunth, Williams, Uzunyan, Tun, Barton and Chang12,Reference Noyes and Edwards26Reference Stout, Daniels and Aboulhosn28 However, during the first few years of life, it is not known how symptomatic or functional patients are while not in the hospital. This study found nearly 2/3 of patients had continued limited functional status with>1/4 indicating marked limitation. Recent work by Han, et al utilised a functional status Scale before and after CHD surgery, finding only 5% of patients had new morbidity at time of discharge. Reference Glotzbach, Ward and Marietta29 Our results suggest that whether the morbidity associated with limited functional status is new or not (which was not assessed without having pre-hospitalisation baseline data), there is a meaningful percentage of patients that could be targeted with services to improve their functional status. More broadly than functional status, patients and families self-reported health status perception was notably lower than reported in other paediatric chronic conditions such as asthma, rheumatologic disease, or diabetes. Reference McClung, Glidewell and Farr16,Reference Baer, Scherer, Fleegler and Hassan20 This could be attributable to the selection bias of a more severe cohort of patients with heart disease, but nonetheless identifies a gap in optimal care and can serve as a starting point for improving care for a highly complex, severe population cared for within paediatric heart centres.

Productivity and costs

School absenteeism is recognised within paediatric public health as a primary indicator of poor health and predictive of future poor health. Reference Stout, Daniels and Aboulhosn28 As outcomes for CHD become increasingly longitudinal, similar to other chronic conditions, indicators such as school absenteeism serve as an opportunity to target to improve overall health. Until this time, school absenteeism was not well-known within CHD patients. A prior single-centre study from Europe found the majority of patients had school or work absenteeism, with 15% of this being attributable to CHD, though the median days missed was only 3 days per year. Reference Glotzbach, Ward and Marietta29 This cohort was for all CHD, as compared to the current study which focuses on the most severe patients and finds that they miss significantly more school. At>4 days per month of missed school (1/4 of patients in the cohort), patients qualify as chronic absenteeism, which is included in recommendations for repeating school years or having additional educational resources to prevent remediation (https://www2.ed.gov/datastory/chronicabsenteeism.html).

Similarly, parental work absenteeism is anecdotally a known problem within the CHD population, given the often long and recurrent hospitalisations in regionalised facilities. However, there are limited data as to how much time or potential income is lost to families due to their child’s CHD. A recent study into CHD parental stressors identified a mean of 37 days in the hospital over the first year of a patient’s life with complex CHD. Reference Han, Yang and Ling30 Over half of working parents in this study missed work time in the preceding month, which importantly was during a phase of stability, and does not represent the time of likely highest work time missed. Coupled with the findings that over half of families spend >$250 per month (extrapolated to >$3000 out of pocket costs per year), these findings suggest that to truly optimise end-user outcomes—those of the family—opportunities exist that are not currently being addressed.

Household material hardship

Living in poverty is associated with poor health outcomes for children, particularly those with chronic illness or medical complexity. Reference Lisanti33Reference Kachmar, Watson, Wypij, Perry and Curley38 With 21% of children in America living below the federal poverty limit and 43% living below 200% of the federal poverty limit, this is a particularly prevalent threat to child health and wellbeing. Reference Lisanti33,Reference Berkowitz, Hulberg, Standish, Reznor and Atlas39Reference Jiang and Granja41 Among children with CHD, socioeconomic status is associated with disparities in mortality and health resource utilisation. Reference Asch, Kerr and Keesey42,Reference Best, Vieira, Glinianaia and Rankin43 Furthermore, children with CHD are living longer, with more co-morbidities, higher medical resource utilisation, and increasing costs. Reference Anderson, Fieldston, Newburger, Bacha and Glied44,Reference Singh, Gauvreau, Bastardi, Blume and Mayer45 These trends pose a dual burden, both for the healthcare system and for patient families. While numerous studies have demonstrated SES-associated outcome disparities among children with CHD, targetable socioeconomic status interventions have not been identified. Reference Singh, Gauvreau, Bastardi, Blume and Mayer45 The household material hardship tool utilised in this project has led to improvements in accessing social support in the oncology population and may serve as an intervenable measure within the CHD population. Reference Schidlow, Gauvreau, Patel, Uzark and Brown46,Reference Gupta, de Wit and McKeown47

Limitations

The external application and broader replicability of this project have notable limitations. The patient population represented those on the severe end of the severity spectrum of CHD. While an important population to focus on given the disproportionate resource utilisation, the results may not be generalisable to the higher number of patients with milder disease. Additionally, while the race/ethnicity of both cohorts were primarily White, the acute cohort does have a higher rate of those indicating Black or Other. This was not statistically significant, but may have been negatively impacted by the follow-up survey being conducted during the COVID-19 era, a time in which access to medical teams disproportionally affected underrepresented minorities. The COVID-19 pandemic could have impacted the data of the chronic phase (2020–2021), particularly in regard to school and work absenteeism, though that was not commented in free-text open-ended responses from families pertaining to absenteeism. While the institution cares for international referrals frequently, the longitudinal nature of the study biased the inclusion to include only patients from the US. As a survey-based study, there is potential for response bias and different characteristics within those who did not respond. Finally, as an observational qualitative study, statistical analyses were not as robust as if there were greater number of patients.

Conclusion

While this project represents an initial look into family-reported data of patients with CHD, the ability to systematically and operationally measure outcomes of importance to families is crucial to generating high-value service delivery. Organisations such as the International Consortium of Health Outcomes Measures have begun to develop sets of core outcomes across integrated conditions such as CHD, with the goal of driving value-based healthcare in a patient-centric approach. Reference Porter9 The CHD set of outcomes, which has significant overlap with the questions asked in this project’s survey, offers the opportunity for implementation and generation of similar datasets across centres for benchmarking and improvement. Reference Oates, Jackson, Partridge, Singh, Fouad and Bae48 In addition to measuring the outcomes, these data suggest the wide net of stakeholders within an integrated care team required to optimally deliver care to patients and families with CHD.

Acknowledgements

The Boston Children’s Hospital patients and families.

Financial support

Supported by grant from Fredric Lovejoy Resident Research and Education Fund, and Grousbeck Fazzalari Fund For Cardiology Research, Department of Cardiology Boston Children’s Hospital.

Competing interests

None.

References

Burstein, DS, Shamszad, P, Dai, D, et al. Significant mortality, morbidity and resource utilization associated with advanced heart failure in congenital heart disease in children and young adults. Am Heart J 2019; 209: 919.CrossRefGoogle ScholarPubMed
Edelson, JB, Rossano, JW, Griffis, H, et al. Emergency department visits by children with congenital heart disease. JACC 2018; 72: 18171825.CrossRefGoogle Scholar
Islam, S, Kaul, P, Tran, DT, Mackie, AS. Health care resource utilization among children with congenital heart disease: a population-based study. Can J Cardiol 2018; 34: 12891297.CrossRefGoogle Scholar
Tuomela, KE, Gordon, JB, Cassidy, LD, Johaningsmeir, S, Ghanayem, NS. Resource utilization associated with extracardiac co-morbid conditions following congenital heart surgery in infancy. Pediatr Cardiol 2017; 38: 10651070.CrossRefGoogle ScholarPubMed
GBD. 2017 Collaborators, Global, Regional, and National Burden of Congenital Heart Disease, 1990-2017: A Systematic Analysis for The Global Burden of Disease Study 2017. Lancet Child Adolesc Health, London, 2020.Google Scholar
Daliento, L, Cecchetto, A, Bagato, F, Dal Bianco, L. A new view on congenital heart disease: clinical burden prevision of changing patients. J Cardiovasc Med 2011; 12: 487492.CrossRefGoogle ScholarPubMed
Pasquali, SK, Sun, J-L, d'Almada, P, et al. Center variation in hospital costs for patients undergoing congenital heart surgery. Circ Cardiovasc Qual Outcomes 2011; 4: 306312.CrossRefGoogle Scholar
Lee, VS, Miller, T, Daniels, C, Paine, M, Gresh, B, Betz, AL. Creating the exceptional patient experience in one academic health system. Acad Med 2016; 91: 338344.CrossRefGoogle ScholarPubMed
Porter, ME. What is value in health care? N Engl J Med 2010; 363: 24772481.CrossRefGoogle ScholarPubMed
Gerardin, JF, Menk, JS, Pyles, LA, Martin, CM, Lohr, JL. Compliance with adult congenital heart disease guidelines: are we following the recommendations? Congenit Heart Dis 2016; 11: 245253.CrossRefGoogle Scholar
Skogby, S, Moons, P, Johansson, B, et al. Outpatient volumes and medical staffing resources as predictors for continuity of follow-up care during transfer of adolescents with congenital heart disease. Int J Cardiol 2020; 310: 51–57. doi: 10.1016/j.ijcard.2020.01.016.CrossRefGoogle ScholarPubMed
Vaikunth, SS, Williams, RG, Uzunyan, MY, Tun, H, Barton, C, Chang, PM. Short-term outcomes following implementation of a dedicated young adult congenital heart disease transition program. Congenit Heart Dis 2018; 13: 8591.CrossRefGoogle Scholar
Sood, E, Karpyn, A, Demianczyk, AC, et al. Mothers and fathers experience stress of congenital heart disease differently: recommendations for pediatric critical care. Pediatr Crit Care Med 2018; 19: 626634.CrossRefGoogle ScholarPubMed
Chong, LSH, Fitzgerald, DA, Craig, JC, et al. Children’s experiences of congenital heart disease: a systematic review of qualitative studies. Eur J Pediatr 2018; 177: 319336.CrossRefGoogle ScholarPubMed
Marino, BS, Lipkin, PH, Newburger, JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the AHA. Circulation 2012; 126: 11431172.CrossRefGoogle Scholar
McClung, N, Glidewell, J, Farr, SL. Financial burdens and mental health needs in families of children with congenital heart disease. Congenit Heart Dis 2018; 13: 554562.CrossRefGoogle ScholarPubMed
Morell, E, Miller, MK, Lu, M, et al. Parent and physician understanding of prognosis in hospitalized children with advanced heart disease. J Am Heart Assoc 2021; 10: e018488.CrossRefGoogle Scholar
Willems Dëlle, CM, Joore, MA, Nieman, FHM, Severens, JL, Wouters, EFM, Hendriks, JJE. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders. Int J Technol Assess 2009; 25: 391399.CrossRefGoogle Scholar
Franklin, RCG, Jacobs, JP, Krogmann, ON, et al. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and the international pediatric and congenital cardiac code. Cardiol Young 2008; 18: 7080.CrossRefGoogle Scholar
Baer, TE, Scherer, EA, Fleegler, EW, Hassan, A. Food insecurity and the burden of health-related social problems in an urban youth population. J Adolescent Health 2015; 57: 601607.CrossRefGoogle Scholar
Balestroni, G, Bertolotti, G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis 2012; 78: 155159.Google ScholarPubMed
Berghammer, M, Karlsson, J, Ekman, I, Eriksson, P, Dellborg, M. Self-reported health status (EQ-5D) in adults with congenital heart disease. Int J Cardiol 2013; 165: 537543.CrossRefGoogle Scholar
Harris, PA, Taylor, R, Theilke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377381.CrossRefGoogle Scholar
SAS Institute Inc. SAS® 9.4 Statements: Reference. SAS Institute Inc, Cary, NC, 2013.Google Scholar
Noyes, J, Edwards, RT. EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review. Value Health 2011; 14: 11171129.CrossRefGoogle ScholarPubMed
Raissadati, A, Haukka, J, Pätilä, T, Nieminen, H, Jokinen, E. Chronic disease burden after congential heart surgery: a 47-year population-based study with 99% follow-up. J Am Heart Assoc 2020; 9(9): e015354. doi: 10.1161/JAHA.119.015354.CrossRefGoogle Scholar
Stout, KK, Daniels, CJ, Aboulhosn, JA, et al. AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2018; 73: 14941563.CrossRefGoogle Scholar
Glotzbach, KL, Ward, JJ, Marietta, J, et al. The benefits and bias in neurodevelopmental evaluation for children with congenital heart disease. Pediatr Cardiol 2020; 41: 327333.CrossRefGoogle ScholarPubMed
Han, B, Yang, JK, Ling, AY, et al. Early functional status after surgery for congenital heart disease: a single-center retrospective study. Pediatr Crit Care Med 2022; 23: 109117.CrossRefGoogle ScholarPubMed
Allison, MA, Attisha, E, De Pinto, CD, et al. The link between school attendance and good health. Pediatrics February 2019; 143: e20183648.Google ScholarPubMed
Na, I, Van Bulck, L, Rassart, J, et al. Absence from work or school in young adults with congenital heart disease: is illness identity associated with absenteeism? Eur J Cardiovasc Nur 2022; 21: 491498.CrossRefGoogle ScholarPubMed
Lisanti, AJ. Parental stress and resilience in CHD: a new frontier for health disparities research. Cardiol Young 2018; 28: 11421150.CrossRefGoogle ScholarPubMed
Gitterman, BA, Flanagan, PJ, Cotton, WH Council on Community Pediatrics, et al. Poverty and child health in the United States. Pediatrics 2016; 137: e20160339.Google Scholar
Frank, DA, Casey, PH, Black, MM, et al. Cumulative hardship and wellness of low-income, young children: multisite surveillance study. Pediatrics 2010; 125: e1115e1123.CrossRefGoogle ScholarPubMed
Bona, K, London, WB, Guo, D, Frank, DA, Wolfe, J. Trajectory of material hardship and income poverty in families of children undergoing chemotherapy: a prospective cohort study. Pediatr Blood Cancer 2016; 63: 105111.CrossRefGoogle Scholar
Garg, A, Toy, S, Tripodis, Y, Silverstein, M, Freeman, E. Addressing social determinants of health at well child care visits: a cluster RCT. Pediatrics 2015; 135: e296e304.CrossRefGoogle ScholarPubMed
Kachmar, AG, Watson, RS, Wypij, D, Perry, MA, Curley, MAQ, For the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Investigative Team. Association of socioeconomic status with postdischarge pediatric resource use and quality of life. Crit Care Med 2022; 50: e117e128.CrossRefGoogle ScholarPubMed
Berkowitz, SA, Hulberg, AC, Standish, S, Reznor, G, Atlas, SJ. Addressing unmet basic resource needs as part of chronic cardiometablic disease management. Jama Intern Med 2017; 177: 244252.CrossRefGoogle Scholar
O’Connor, GT, Quinton, HB, Kneeland, T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003; 111: e333e339.CrossRefGoogle Scholar
Jiang, Y, Granja, MR. Basic Facts about Low-Income Children: Children under 18 years. National Center for Children in Poverty, Columbia University Mailman School of Public Health, New York, 2015.Google Scholar
Asch, SM, Kerr, EA, Keesey, J, et al. Who is at greatest risk for receiving poor-quality health care? New Engl J Med 2006; 354: 11471156.CrossRefGoogle ScholarPubMed
Best, KE, Vieira, R, Glinianaia, SV, Rankin, J. Socio-economic inequalities in mortality in children with congenital heart disease: a systematic review and meta-analysis. Paediatr Perinat Epidemiol 2019; 33: 291309.CrossRefGoogle ScholarPubMed
Anderson, BR, Fieldston, ES, Newburger, JW, Bacha, EA, Glied, SA. Disparities in outcomes and resource use after hospitalization for cardiac surgery by neighborhood income. Pediatrics 2018; 141: e20172432.CrossRefGoogle ScholarPubMed
Singh, TP, Gauvreau, K, Bastardi, HJ, Blume, ED, Mayer, JE. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail 2009; 2: 160165.CrossRefGoogle ScholarPubMed
Schidlow, DN, Gauvreau, K, Patel, M, Uzark, K, Brown, DW. Site of interstage care, resource utilization, and interstage mortality: a report from the NPC-QIC registry. Pediatr Cardiol 2015; 36: 126131.CrossRefGoogle ScholarPubMed
Gupta, RP-S, de Wit, ML, McKeown, D. The impact of poverty on the current and future health status of children. Paediatr Child Health 2007; 12: 667672.CrossRefGoogle ScholarPubMed
Oates, GR, Jackson, BE, Partridge, EE, Singh, KP, Fouad, MN, Bae, S. Sociodemographic patterns of chronic disease. Am J Prev Med 2017; 52: S31S39.CrossRefGoogle ScholarPubMed
Hummel, K, Whittaker, S, Sillett, N, et al. Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the international consortium for health outcomes measurement congenital heart disease working group. Eur Heart J Qual Care Clin Outcomes 2021; 7: 354365.CrossRefGoogle Scholar
Figure 0

Figure 1. Productivity burden percentages of total respondents by type of burden.

Figure 1

Table 1. Patient demographics.

Figure 2

Table 2. Patient and parent demographics by household material hardship categorisation in the chronic phase of illness.

Figure 3

Figure 2. Quality of life during the chronic phase of illness. HMH = household medical hardship; IQR = interquartile range; QOL = quality of life.